Navigation Links
Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features

New surface addresses key factors in the prevention and treatment of

pressure ulcers to enhance patient safety and comfort

BATESVILLE, Ind., Oct. 11 /PRNewswire-FirstCall/ -- Hillenbrand Industries, Inc. (NYSE: HB) today announced its Hill-Rom subsidiary has introduced a revolutionary new hospital bed surface that can enhance care for patients with pressure ulcers. The Hill-Rom(R) E700 Wound Surface (a low air loss therapy surface) also offers new levels of flexibility for use within health care facilities. Unlike traditional mattress replacement systems, this surface easily converts to fit multiple bed frames, including Hill-Rom frames and a variety of other frames.

"We at Hill-Rom are focused on innovation that enhances outcomes for patients and their caregivers," said Peter Soderberg, president and CEO of Hillenbrand Industries and Hill-Rom. "This new therapy surface should enhance patient safety and represents the next generation of technology in wound care surfaces, offering the latest technological advancements in pressure ulcer treatment."

Caregivers are at the frontline in understanding the importance of preventing and treating pressure ulcers. They also understand the need for comfort. "Our goal is to prevent pressure ulcers and to create a safe environment," said Janice Thomas, RN, director of the Wound Care Clinic at Gaston Memorial Hospital in Gastonia, NC. "However, what's really different is that our patients find it so comfortable and that's important, too. This bed offers pressure reduction and, equally important to us, is comfortable for our patients."

Melissa Fitzpatrick, RN, MSN, FAAN, vice president and chief clinical officer for Hill-Rom, agrees and adds, "Not only does the new E700 surface provide the therapy pressure that ulcer patients need, it also offers them the comfort they may have been missing in traditional therapy surfaces. And, as we all know, quality rest can promote faster healing."

She continues, "A primary need for caregivers is a wound therapy surface that not only reduces shear, friction and pressure, but also helps keep the patient cool, dry and comfortable. Our new Hill-Rom E700 Wound Surface delivers these features and is a powerful tool for helping nurses provide the best in patient care by offering a new way to help manage pressure, patient microclimate and comfort."

Avoiding pressure ulcers has assumed greater importance for hospitals since the Centers for Medicare and Medicaid Services (CMS) announced recently that treatment of hospital-acquired pressure ulcers will not be reimbursed as of October 2008. In addition, The Joint Commission has made pressure ulcer prevention one of its National Patient Safety Goals for 2008. The impact of these issues has been quantified in the 10th Annual International Pressure Ulcer Prevalence Survey (IPUPS) released by Hill-Rom last month. This report highlights that nearly half of adult patients in acute care facilities are at high risk for the development of pressure ulcers.

The Hill-Rom E700 Wound Surface offers a new solution and contains numerous unique features to promote patient comfort and healing:

-- PressureSmart(TM) Sensing Technology senses the patient in real time

and automatically adjusts to provide optimal pressure redistribution

as the patient sleeps, turns, sits up, and gets in and out of bed.

-- Microclimate Management is provided by E700's unique Low Airloss 3-D

fabric with crush-resistant channels. It provides airflow just below

the patient, leading to an improved ability to manage heat and

moisture, thus avoiding breakdown of the skin that could lead to

pressure ulcers.

-- ShearRelief(TM) System fabric is slippery and moves with the patient,

minimizing shear and friction. A unique algorithm automatically

adjusts to help reduce shear and friction when the head of the bed is


-- Bed exit alarms integrated into this mattress help reduce the risk of

falls and are an industry first.

-- Head of Bed Angle Display lets the caregiver know if a patient's head

is above or below the 30-degree point, a key factor in reducing the

incidence of ventilator-associated pneumonia.

-- Turn Assist, built into the bed surface, allows caregivers to more

easily reposition patients, easing strain on caregivers and

maintaining patient comfort.

-- QuickStudy(TM) Bed-Side In-Servicing is the first software-based

bed-side display to provide caregivers user instructions and video

demonstrations. This bilingual tool supports the caregiver with an

easy-to-use, touch-screen help tool.

The Hill-Rom(R) E700 Wound Surface (a low air loss therapy surface) will be introduced today at the Clinical Symposium on Advances in Skin and Wound Care Conference (CSWC) being held in Nashville.


Hillenbrand Industries is organized into two operating companies serving the health care and funeral services industries.

Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals, and workflow information technology solutions. Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

Hill-Rom ... enhancing outcomes for patients and their caregivers.

Batesville Casket Company is a leader in the North American death care industry through the sale of funeral services products, including burial caskets, cremation caskets, containers and urns, selection room display fixturing and other personalization and memorialization products. Batesville Casket Company ... helping families honor the lives of those they love.

Hillenbrand Disclosure Regarding Forward-Looking Statements

Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections. The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "would," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology. The absence of such terms, however, does not mean that the statement is not forward-looking. It is important to note that forward- looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward- looking statements. Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large national providers and group purchasing organizations, changes in death rates, whether the Company's new products are successful in the marketplace, changes in customers' Medicare reimbursements, the success of the implementation of the Company's enterprise resource planning system, compliance with FDA regulations, anti-trust litigation, potential exposure to product liability or other claims, failure of the Company's announced strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, disruptions in the Company's business or other adverse consequences resulting from the potential separation of the Company's two operating companies, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, competition from nontraditional sources in the funeral services business, volatility of the Company's investment portfolio, increased costs or unavailability of raw materials, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters. For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's Annual Report on Form 10-K for the period ended September 30, 2006. The Company assumes no obligation to update or revise any forward-looking statements.

SOURCE Hillenbrand Industries, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. GE Healthcare introduces MR imaging product
2. Online fishing site introduces interactive maps
3. GE introduces remotely hosted health services
4. Norlight introduces new e-mail security service
5. Angel network introduces ePlan
6. RedPrairie Corp. introduces new supply chain software
7. GE introduces compact ultrasound system for women
8. MailFoundry introduces new e-mail archive product
9. Madison biotech introduces drug discovery advance
10. Alfalight introduces new 25-watt pump module
11. Wisconsin introduces new state IT plan
Post Your Comments:
(Date:11/24/2015)... - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: AEZ) (the "Company"), ... Toronto Stock Exchange, confirms that as of the date ... that would cause the recent movements in the Company,s ... About Aeterna Zentaris Inc. . ... Zentaris is a specialty biopharmaceutical company engaged in developing ...
(Date:11/24/2015)... , November 24, 2015 ... new market research report "Oligonucleotide Synthesis Market by Product ... (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical ... published by MarketsandMarkets, the market is expected to reach ... in 2015, at a CAGR of 10.1% during the ...
(Date:11/24/2015)... Muncie, IN (PRWEB) , ... November 24, 2015 , ... ... its newest Special Interest Group (SIG), MultiGP, also known as Multirotor Grand Prix, to ... in the last few years. Many AMA members have embraced this type of racing ...
(Date:11/24/2015)... 2015 --> ... released by Transparency Market Research, the global non-invasive prenatal ... of 17.5% during the period between 2014 and 2022. ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ... market to reach a valuation of US$2.38 bn by ...
Breaking Biology Technology:
(Date:11/9/2015)... , Nov. 09, 2015 ... addition of the "Global Law Enforcement ... offering. --> ) has ... Law Enforcement Biometrics Market 2015-2019" report ... and Markets ( ) has announced ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has ... to provide preclinical development services to the National Cancer ... SRI will provide scientific expertise, modern testing and support ... of preclinical pharmacology and toxicology studies to evaluate potential ... --> The PREVENT Cancer Drug Development Program is ...
(Date:10/29/2015)... RESTON, Va. , Oct. 29, 2015 ... announced today that it has released a new version ... Daon customers in North America ... gains. IdentityX v4.0 also includes a FIDO UAF ... customers are already preparing to activate FIDO features. These ...
Breaking Biology News(10 mins):